Skip to main content

Laurie Joseph, Ph.D

Dr. Joseph has over 35 years of experience in toxicology having developed clinical and in vitro human models plus in vivo animal models to understand the fundamentals of cellular damage their response to environmental toxins. She received a B.S. in geology from The George Washington University, a M.S. and Ph.D. from The Ohio State University with post-doctoral training at Yale University and the University Connecticut Medical Center. Her present studies include skin, gut and vascular tissue wound repair with over 20 years of experience in the personal care industry. She is a member of the Personal Care Product Council, Society of Cosmetic Chemists, Society of Toxicology and American Academy of Dermatology. Prior to coming to Rutgers University, she was the senior skin biologist for Croda Inc. She has over 40 peer reviewed publications, over 100 presentations worldwide, is a journal reviewer and has extramural funding. Dr Joseph is an associate research professor in the Ernest Mario School of Pharmacy at Rutgers University where she has mentored over 40 graduate and undergraduate students.  Her academic service includes membership in the New Jersey Institute for Food, Nutrition, and Health; Center for Lipid Research; the Rutgers School of Graduate Studies; and the Joint Graduate Program in Toxicology, Rutgers University Piscataway, NJ. Dr. Joseph’s primary research focus is in the development of in vivo, in vitro, and clinical models of skin wound repair with the goal of developing countermeasures to mitigate chemical warfare injuries.  Dr. Joseph is a member of the Rutgers University CounterACT Center for Excellence.

Research Interests:  Mechanism of skin injury and repair due to environmental toxins including vesicating agents, characterization of the molecular alterations during different stages of wound repair, and preparation of topical formulations to mitigate injury. Development of in vitro and clinical models of skin wound repair, in vitro models for study of transepithelial penetration of pharmaceutical and chemical agents via topical, oral and inhaled routes of administration.

Matthew Sills, Ph.D

matthew sills headshotDr. Matthew Sills is currently a Professor of Professional Practice in the Professional Science Master’s program at Rutgers University. In this position, he teaches in the Drug Discovery & Development concentration, advises students in the Life Science concentrations (including Personal Care Science) and develops curricula for programs in the Life Sciences. Dr. Sills has 27 years of experience in the pharmaceutical industry, having worked at Ciba-Geigy/Novartis, Pharmacopeia, AD-4 Pharma and Merck. During his career, Dr. Sills gained experience in the areas of lead discovery, lead optimization, and preclinical development having worked on projects in the inflammation, cardiovascular disease, oncology and neuroscience therapeutic areas.

 

Francois Berthiaume, Ph.D

francois berthiaume headshotFrancois Berthiaume is an Associate Professor in the Department of Biomedical Engineering at Rutgers, The State University of New Jersey. Dr. Berthiaume received a BS degree in Chemical Engineering from Laval University, Quebec City, Canada, and a PhD in Chemical Engineering from The Pennsylvania State University. After post doctoral studies at the Center for Engineering in Medicine at Massachusetts General Hospital / Harvard Medical School, he was promoted to faculty rank in the same institution. In 2009, he was recruited to the Department of Biomedical Engineering at Rutgers University. His research has been funded by numerous awards from private, state, and federal agencies, including the Whitaker Foundation, the Deshpande Center for Technological Innovation, the New Jersey Commission on Spinal Cord Research, the Department of Defense, and the National Institutes of Health. He has published over 150 peer-reviewed papers.

Research interests:
Dr. Berthiaume’s research interests are in the general areas of tissue engineering and metabolic engineering, with a particular focus on technologies to promote wound healing.  In the area of skin wound healing, Dr. Berthiaume has extensive experience in animal models of burn injury as well as pressure sores, and in the development of various modalities to improve the wound healing process of these injuries. Recently, we have developed, using fusion protein technology, recombinant proteins that exhibit increased stability and efficacy in the chronic wound environment.

 

Sanjeeva Murthy, Ph.D

sanjeeva murthy headshotDr. Sanjeeva Murthy is a Materials Scientist and has been a research faculty at the New Jersey Center for Biomaterials, Rutgers University since 2007.  Before coming to Rutgers, he was an Associate Professor in Physics for more than 4 years at the University of Vermont.  Prior to that, he worked at Honeywell for 21 years, which he left in 2002 while he was a Senior Principal Scientist there.  He did his postdoctoral work at MIT, the New York State Department of Health and Carnegie Mellon University.  He obtained his Ph.D. in Materials Science from the University of Connecticut.  He came to the U.S. after obtaining a Master’s degree from the Indian Institute of Science in Bangalore, India.

Research interests:
Dr. Murthy’s expertise is in the physical properties of materials, polymers processing, and fabrication of devices.  He develops structure-property relationships using a variety of techniques including rheology, and related techniques for tailoring polymers for biomedical applications.

 

William Welsh, Ph.D

william welsh headshotDr. William J. (Bill) Welsh holds the Norman H. Edelman Endowed Professorship in Bioinformatics in the Department of Pharmacology at the Robert Wood Johnson Medical School (RWJMS), Rutgers University in Piscataway NJ. Concurrently, he serves as Associate Director of the Division of Cheminformatics of the Biomedical Informatics Shared Resource at the Rutgers-Cancer Institute of New Jersey (R-CINJ). He also serves as a faculty investigator at Princeton University in the Department of Chemistry.
Dr. Welsh received a B.S. degree magna cum laude in Chemistry from St. Joseph’s University (Philadelphia, PA). He earned a Ph.D. in Theoretical Physical Chemistry from the University of Pennsylvania (Philadelphia, PA). He then conducted postdoctoral studies in computational physical chemistry in the Department of Chemistry at the University of Cincinnati (Cincinnati, OH) and at the National Institutes of Health (NIH).